Lawrence Tanenbaum, MD, FACR, Director of CT, MR & Advanced Imaging and Vice President, Medical Director of the Eastern Region at RadNet, Inc. joins Cortechs.ai Scientific Advisory Board
(San Diego, CA) Cortechs.ai, the leading medical software innovator providing solutions for quantitative brain volume analysis, is pleased to announce a new member to its Scientific Advisory Board, Dr. Lawrence Tanenbaum.
Dr. Tanenbaum received his M.D. from the University of California, San Diego, School of Medicine, after which he completed his residency and fellowship training in diagnostic radiology at the University of Southern California. In 2015, he joined RadNet, Inc., as the Director of CT, MR & Advanced Imaging and Vice President, Medical Director of the Eastern Region. From 2008-2015, Dr. Tanenbaum was an Associate Professor of Radiology, Director of MRI, CT and Outpatient / Advanced Imaging Development the Icahn School of Medicine at Mount Sinai School of Medicine in New York. Prior to 2008, Dr. Tanenbaum served as the Director of MRI, CT and Neuroradiology at the JFK Medical Center / New Jersey Neuroscience Institute.
“I am excited to join the Cortechs.ai Scientific Advisory Board and I am enthusiastic about NeuroQuant, LesionQuant and future developments at Cortechs.ai”, said Dr. Tanenbaum. “I’m excited by the potential of NeuroQuant and LesionQuant to change how physicians assess neurodegenerative disorders, such as dementia, epilepsy, traumatic brain injury and multiple sclerosis.”
“With his extensive neuroradiology and medical imaging background, Dr. Tanenbaum brings a wealth of knowledge and experience to our team,” said Guri Stark, CEO of Cortechs.ai. “We look forward to him advising us and helping us steer the future direction of quantitative imaging at Cortechs.ai and in providing his guidance on our current quantitative brain imaging products, NeuroQuant, LesionQuant and PETQuant.”
Cortechs.ai develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. Cortechs.ai’ cutting-edge brain imaging analysis provides neurologists, radiologists, and clinical researchers worldwide with a convenient and cost-effective means to quantify subcortical structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma and brain development. Please visit cortechs.ai for further information.